These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 10189681)
1. [Antiretroviral therapy 1998/1999: what is our current status?--Avoiding therapy failure instead of expecting it]. Zangerle R Wien Med Wochenschr; 1998; 148(23-24):527-9. PubMed ID: 10189681 [TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
3. Treatment interruptions in HIV-infected subjects. Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398 [TBL] [Abstract][Full Text] [Related]
4. Current management challenges in HIV: antiretroviral resistance. Kuritzkes DR; Boyle BA; Gallant JE; Squires KE; Zolopa A AIDS Read; 2003 Mar; 13(3):133-5, 138-42. PubMed ID: 12728868 [TBL] [Abstract][Full Text] [Related]
5. Genotypic resistance tests in the management of the HIV-infected patient at virological failure. Aceti A; Carosi G Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection. Fischl MA AIDS; 1999 Sep; 13 Suppl 1():S49-59. PubMed ID: 10546785 [TBL] [Abstract][Full Text] [Related]
7. Antiretroviral update: recent advances expand options for patients with HIV. Santhanam H; Goins M Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568 [No Abstract] [Full Text] [Related]
8. [Salvage therapy in HIV infection]. Salzberger B MMW Fortschr Med; 2004 Apr; 146 Spec No 1():52, 54-5, 57. PubMed ID: 15373050 [TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy for HIV infection: a review of current medications and therapies. Bright DC J Am Optom Assoc; 1999 Jun; 70(6):355-83. PubMed ID: 10437339 [TBL] [Abstract][Full Text] [Related]
10. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337 [TBL] [Abstract][Full Text] [Related]
11. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
12. [Drug resistance in antiretroviral therapy of HIV infection]. Oette M; Häussinger D Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670 [TBL] [Abstract][Full Text] [Related]
15. Developments in HIV treatments: strategies for success. Piliero P AIDS Read; 2004 Dec; 14(12):655-65. PubMed ID: 15619781 [TBL] [Abstract][Full Text] [Related]
16. Future implications: compliance and failure with antiretroviral treatment. Patel AK; Patel KK J Postgrad Med; 2006; 52(3):197-200. PubMed ID: 16855321 [TBL] [Abstract][Full Text] [Related]
17. Strategic approaches to antiretroviral treatment. Havlir DV Top HIV Med; 2003; 11(4):145-9. PubMed ID: 12876333 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. Lucas GM J Antimicrob Chemother; 2005 Apr; 55(4):413-6. PubMed ID: 15722389 [TBL] [Abstract][Full Text] [Related]
20. Current status and future issues in the treatment of HIV-1 infection. Matsushita S Int J Hematol; 2000 Jul; 72(1):20-7. PubMed ID: 10979204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]